Table 2.
Implant Material | Implant Site | Tumor Type | Postoperative Observations | Reference |
---|---|---|---|---|
Titanium alloy | Upper cervical spine (between C1 and C3) | Ewing sarcoma | Uneventful recovery The patient began to ambulate on postoperative day 7 and started adjuvant treatment 3 weeks after surgery Tumor-free at the 1-year follow-up |
[75] |
Titanium alloy | Cervical spine (between C2 and C6) | Chordoma | No postoperative complications The patient was mobilized 48 h after the anterior intervention, was discharged after 10 days, and was required to wear a neck brace for 10 days No change in implant position, no evidence of hardware failure, and no significant adverse effects at 14 months follow-up Tumor-free at the 15 months follow-up |
[76] |
Titanium alloy | Upper cervical spine | Primary osseous spinal tumors | No sign of displacement or subsidence During a mean follow-up of 28.6 months, 1 patient died of systemic metastasis, and 1 had local tumor recurrence, while the other 7 patients were alive and functional in their daily living |
[77] |
Titanium alloy | Thoracolumbar spine (between T10 and L2) | Breast cancer metastasis | The patient was stable 3 days after the operation, and after 6 days, the back pain was significantly alleviated; the patient could walk normally independently with a thoracolumbar brace Tumor-free at the 2 years follow-up |
[78] |
Titanium alloy | Lumbar spine (between L4 and S1) | Renal cell metastasis | No intraoperative complications The patient was mobilized on postoperative day 4 and discharged on day 15 At the 3-month follow-up, the surgical and low back pain settled considerably, but the functional motion range of the lumbar spine remained limited |
[74] |
Porous titanium mesh | Sacrum | Chordoma | Tumor-free at the 18-month follow-up The patient could walk short distances with assistance |
[72] |
Porous titanium mesh | Sacrum | Osteosarcoma | The patient could walk 2 weeks after surgery Due to the resection of the left S1 nerve root, there occurred a left foot drop and neuropathic pain in the left leg The patient underwent 3 cycles of adjuvant chemotherapy up to 12 months after the surgery |
[79] |